NCT07322783 2026-01-07Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET AmplificationQingdao Central HospitalPhase 2 Recruiting60 enrolled
NCT04001777 2025-10-01A Study of APG-1252 Plus Osimertinib(AZD9291) in EGFR TKI Resistant NSCLC PatientsAscentage Pharma Group Inc.Phase 1 Active not recruiting80 enrolled